How do subfield-specific anomalies in CA1 and dentate gyrus contribute to distinct ASD behavioral phenotypes?

OPEN

The abstract identifies structural and functional changes in specific hippocampal subfields but doesn't explain how CA1 versus dentate gyrus dysfunction maps to different ASD symptoms. This knowledge gap limits the development of subfield-targeted interventions and biomarkers. Gap type: unexplained_observation Source paper: Review on the role of hippocampus in autism spectrum disorder: Recent insights into neuropathology, genetics, and emerging therapeutic strategies. (2026, Neurobiology of disease, PMID:41412318)

Priority: 0.71 Domain: neurodevelopment Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: How do subfield-specific anomalies in CA1 and dentate gyrus contribute to distinct ASD behavioral phenotypes? is a 0.71 priority gap in neurodevelopment. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How do subfield-specific anomalies in CA1 and dentate gyrus contribute to distinct ASD behavioral phenotypes? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

0%

Resolution

0

Mechanistic Families

Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (5)

ketamine→CA1ISCHEMIA→CA1CA1→NEURODEGENERATIONLACTATE→CA1CA1→DEPRESSION

associated with (4)

CA1→iron enrichmentCA1→selective vulnerability to neurodegenerationCA1→hippocampal sclerosisIFN→ASD

biomarker for (1)

causes (5)

ASD→INFLAMMATIONASD→GUT_MICROBIOTACA1→AGINGCORTEX→CA1SYNAPTIC PLASTICITY→CA1

characterized by (1)

10.1007_s00702-023-02595-9→ASD

degrades (2)

CA1→NEURONCA1→MICROGLIA

expressed in (2)

pyramidal neurons→CA1CA1→MICROGLIA

impairs (1)

CA1→MICROGLIA

increases (2)

CA1→NEURONSCA1→NEURON

inhibits (6)

ASD→CIRCADIAN_RHYTHMHDAC3→CA1CA1→TAUCA1→ENTORHINAL CORTEXCA1→GLUTAMATERGIC

▸ Show 1 more

CA1→GABAERGIC

interacts with (2)

CA1→AGINGCA1→TAU

phosphorylates (1)

protects against (2)

TAU→CA1CA1→METFORMIN

reduces (2)

CA1→NEURONSCA1→NEURON

regulates (7)

CA1→SYNAPTIC PLASTICITYAMYLOID→CA1CA3→CA1CA1→CHOLESTEROLKETAMINE→CA1

▸ Show 2 more

CA1→PSD95CA1→DENTATE GYRUS

showed association at brain level with (1)

spreads to (1)

CA1→subiculum

stabilizes (1)

treats (4)

AMYLOID→CA1CA1→TAUNEURON→CA1CA1→SYNAPTIC PLASTICITY

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps